- Home
- / Quantum Genomics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Quantum Genomics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
€0.1
2024-10-29
Market Capitalization
€2.5 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 1.2M | 116.0K | 605.0K | 10.0K | |||
| Cost of goods sold | 10.7M | 7.9M | 13.3M | 18.5M | |||
| Gross profit | (10.7M) | (7.8M) | (11.0M) | (15.3M) | 3.0M | 36.0K | |
| Gross profit margin, % | -918.4% | -13185.3% | 499.0% | 360.0% | |||
| Operating expense total | 2.7M | 2.9M | 2.5M | 3.2M | 32.8M | 3.2M | 1.5M |
| Depreciation and amortization | 19.0K | 44.0K | 11.0K | 265.0K | 263.0K | 8.0K | 2.0K |
| EBITDA | (13.3M) | (10.4M) | (13.5M) | (18.4M) | (29.8M) | (3.1M) | (1.5M) |
| EBITDA margin, % | -1124.9% | -15905.2% | -4928.8% | -31280.0% | |||
| EBIT | (13.6M) | (10.6M) | (13.7M) | (19.2M) | (27.1M) | (3.2M) | (1.5M) |
| EBIT margin, % | -1137.0% | -16569.0% | -4477.0% | -31760.0% | |||
| Interest income | 103.0K | 11.0K | 5.0K | 16.0K | |||
| Interest expense | 10.0K | 13.0K | 394.0K | 404.0K | 7.4M | ||
| Pre tax profit | (13.4M) | (10.6M) | (13.7M) | (19.2M) | (27.5M) | (3.2M) | (8.9M) |
| Income tax expense | (1.5M) | (1.5M) | (2.1M) | (2.7M) | (2.5M) | (34.0K) | |
| Net Income | (12.0M) | (9.1M) | (11.5M) | (16.6M) | (24.9M) | (3.2M) | (8.9M) |